Tumblr Yahoos: Old ...
Health Care: Drugs
Ariad Pharmaceuticals (ARIA: NASDAQ)
$16.60 -0.06 | -0.39%
05/20/13 - 12:40 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 119.38M | 306.26M | 103.63M | 40.36M |
| Receivables | 101.00K | 34.00K | 407.00K | 3.58M |
| Inventories | 0.00 | 0.00 | 0.00 | 1.95M |
| Other Current Assets | 3.84M | 1.28M | 1.14M | 0.00 |
| Total Current Assets | 168.35M | 307.57M | 105.17M | 45.90M |
| Property, Plant & Equipment, Gross | 43.90M | 39.98M | 37.76M | 37.57M |
| Accumulated Depreciation & Depletion | 36.22M | 33.37M | 30.73M | 28.83M |
| Property, Plant & Equipment, Net | 7.68M | 6.61M | 7.04M | 8.74M |
| Intangibles | 3.12M | 5.74M | 7.07M | 9.63M |
| Other Non-Current Assets | 1.04M | 791.00K | 749.00K | 749.00K |
| Total Non-Current Assets | 11.84M | 13.14M | 14.86M | 19.11M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 180.19M | 320.71M | 120.03M | 65.01M |
| Accounts Payable | 8.27M | 5.73M | 3.12M | 4.81M |
| Short Term Debt | 2.12M | 1.45M | 1.47M | 11.67M |
| Other Current Liabilities | 698.00K | 1.17M | 829.00K | 787.00K |
| Total Current Liabilities | 48.87M | 25.37M | 16.40M | 37.68M |
| Long Term Debt | 9.10M | 11.22M | 8.29M | 142.00K |
| Deferred Income Taxes | 0.00 | 2.72M | 2.12M | 1.36M |
| Other Non-Current Liabilities | 9.38M | 61.26M | 29.14M | 114.84M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 18.48M | 75.20M | 39.56M | 116.34M |
| Total Liabilities | 67.34M | 100.57M | 55.95M | 154.03M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 112.85M | 220.14M | 64.08M | -89.02M |
| Common Par | 167.00K | 158.00K | 127.00K | 109.00K |
| Additional Paid In Capital | 890.50M | 776.95M | 497.31M | 429.48M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -777.84M | -556.96M | -433.36M | -518.61M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 20.00K | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 121.95M | 231.36M | 72.37M | -88.87M |
| Total Equity | 112.85M | 220.14M | 64.08M | -89.02M |
| Total Liabilities & Stock Equity | 180.19M | 320.71M | 120.03M | 65.01M |
| Total Common Shares Outstanding | 167.08M | 157.61M | 126.94M | 109.04M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 164.96M | 132.38M | 113.02M | 93.33M |
| Diluted Weighted Shares Outstanding | 164.96M | 132.38M | 114.73M | 93.33M |
| Number of Employees | 300 | 150 | 122 | 149 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ARIA
- Portfolio NameUser Type
- ProSteven Cohen - SAC Capital
- ProDaniel Loeb - Third Point
- ContributorBreakout Stocks Of The Week...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorStocks At New 52-Week Highs...
- ContributorStocks Rising On Unusual Vo...
Latest ARIA Headlines from TheStreet
- Biotech Stock Mailbag: MannKind, Ariad, Oncolytics Biotech 04.05.13 | 07:04 am
- Ariad CEO Strikes Back, Insists Leukemia Drug Is Fine 04.04.13 | 10:04 am
- Ariad Stock Falls On Unusually High Volume (ARIA) 04.03.13 | 02:04 pm
- The Survey Says: Ariad's Leukemia Drug Is Toxic 04.03.13 | 01:04 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Ariad Pharmaceuticals (ARIA): Drugs' Highlighted Dud Of The Day 03.28.13 | 05:03 pm
- Ariad Pharma Falls On Weak Leukemia Drug Prescriptions 03.27.13 | 12:03 pm
- Ariad Stock Falls On Unusually High Volume (ARIA) 03.25.13 | 04:03 pm
- Cramer's Top Stock Picks: ARIA ALKS LINE KORS WFM 02.28.13 | 06:02 am
- Cramer's 'Mad Money' Recap: I Told You So 02.27.13 | 08:02 pm
Press Releases for ARIA
- ARIAD Announces That Iclusig™ (Ponatinib) Receives Positive CHMP Opinion For Approval In The European Union - Business Wire 03.22.13 | 08:03 am
- ARIAD Announces Presentations Of Preclinical Data At American Association For Cancer Research Annual Meeting - Business Wire 03.20.13 | 07:03 am
- ARIAD To Present At Barclays Global Healthcare Conference - Business Wire 03.06.13 | 07:03 am
- ARIAD To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.28.13 | 07:02 am
- ARIAD Reports 2012 Financial Results And Outlines Key Objectives For 2013 - Business Wire 02.25.13 | 07:02 am
- Jonathan E. Dickinson, General Manager, ARIAD Pharmaceuticals (Europe), Sàrl (Photo: Business Wire) - Business Wire 02.21.13 | 02:02 am
- ARIAD To Present At The RBC Capital Markets Healthcare Conference - Business Wire 02.19.13 | 07:02 am
- ARIAD To Present At The Leerink Swann Global Healthcare Conference - Business Wire 02.08.13 | 07:02 am
- ARIAD To Webcast Conference Call On Fourth Quarter And Year-End 2012 Financial Results - Business Wire 02.05.13 | 07:02 am
- ARIAD Announces Completion Of Public Offering - Business Wire 01.29.13 | 04:01 pm
Partner Headlines for ARIA
- Pre-Market Earnings Report for February 25, 2013 : LOW, FE, HTZ, DCI, KOS, ARIA, DDD, BGC, CTB, CWH, HL, DNDN - NASDAQ 02.22.13 | 09:02 pm
- Mid-Week Biopharma Catalyst Trades To Consider - Seeking Alpha 12.13.12 | 09:12 am
- UPDATE: Dawson James Initiates Coverage on Ariad Pharmaceuticals with Market Outperform Rating, $32 PT - Benzinga 12.07.12 | 09:12 am
- Data Published on ARIAD Candidate - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- 5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments - Seeking Alpha 10.09.12 | 09:10 am
- ARIAD Seeks Ponatinib Approval - Analyst Blog - Zacks 10.02.12 | 06:10 pm
- ARIAD Partner Withdraws PMA - Analyst Blog - NASDAQ 09.19.12 | 08:09 pm
- 5 Pharmaceutical Companies With EMA Catalysts During The Next 3 - 12 Months - Part II - Seeking Alpha 09.02.12 | 08:09 am
- ARIAD Seeks EU Nod for Ponatinib - Analyst Blog - NASDAQ 08.31.12 | 10:08 pm
- ARIAD Seeks EU Nod for Ponatinib - Analyst Blog - Zacks 08.31.12 | 06:08 pm
